{
    "root": "2f74e47c-ec48-2df0-e063-6294a90a7199",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Amlodipine Besylate",
    "value": "20250303",
    "ingredients": [
        {
            "name": "CELLULOSE, MICROCRYSTALLINE",
            "code": "OP1R32D61U"
        },
        {
            "name": "ANHYDROUS DIBASIC CALCIUM PHOSPHATE",
            "code": "L11K75P92J",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_77635"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A POTATO",
            "code": "5856J3G2A2",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30563"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "AMLODIPINE BESYLATE",
            "code": "864V2Q084H",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_2668"
        }
    ],
    "indications": {
        "text": "amlodipine besylate tablets calcium channel blocker may used alone combination antihypertensive antianginal agents treatment : \u2022 hypertension ( 1.1 ) amlodipine besylate tablets indicated treatment hypertension , lower blood pressure . lowering blood pressure reduces risk fatal nonfatal cardiovascular events , primarily strokes myocardial infarctions . \u2022 coronary artery disease ( 1.2 ) chronic stable angina vasospastic angina ( prinzmetal \u2019 variant angina ) angiographically documented coronary artery disease patients without heart failure ejection fraction < 40 %",
        "doid_entities": [
            {
                "text": "hypertension (DOID:10763)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10763"
            },
            {
                "text": "coronary artery disease (DOID:3393)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_3393"
            },
            {
                "text": "artery disease (DOID:0050828)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_0050828"
            },
            {
                "text": "disease (DOID:4)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_4"
            },
            {
                "text": "variant angina (DOID:0111151)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_0111151"
            }
        ],
        "orphanet_entities": [
            {
                "disease": "chronic stable angina",
                "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_458775"
            }
        ]
    },
    "contraindications": {
        "text": "adult recommended starting dose : 5 mg daily maximum dose 10 mg daily . ( 2.1 ) small , fragile , elderly patients , patients hepatic insufficiency may started 2.5 mg daily . ( 2.1 ) pediatric starting dose : 2.5 mg 5 mg daily . ( 2.2 ) important limitation : doses excess 5 mg daily studied pediatric patients . ( 2.2 )",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "2.5 mg tablets amlodipine besylate tablets , usp 2.5 mg ( amlodipine besylate equivalent 2.5 mg amlodipine per tablet ) supplied white white , round , flat-faced , beveled edge tablets '211 ' debossed one side plain side supplied follows : ndc : 70518-1971-00 ndc : 70518-1971-01 ndc : 70518-1971-02 packaging : 30 1 blister pack packaging : 90 1 bottle plastic packaging : 30 1 blister pack storage store 20\u00b0 25\u00b0c ( 68\u00b0 77\u00b0f ) , excursions permitted 15\u00b0 30\u00b0c ( 59\u00b0 86\u00b0f ) ( usp controlled room temperature ) , dispense tight , light resistant container ( usp ) . repackaged distributed : remedy repack , inc. 625 kolter dr. suite # 4 indiana , pa 1-724-465-8762",
    "adverseReactions": "amlodipine besylate tablets contraindicated patients known sensitivity amlodipine .",
    "indications_original": "Amlodipine besylate tablets is a calcium channel blocker and may be used alone or in combination with other antihypertensive and antianginal agents for the treatment of: \u2022 Hypertension ( 1.1 ) Amlodipine besylate tablets is indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. \u2022 Coronary Artery Disease ( 1.2 ) Chronic Stable Angina Vasospastic Angina (Prinzmetal\u2019s or Variant Angina) Angiographically Documented Coronary Artery Disease in patients without heart failure or an ejection fraction < 40%",
    "contraindications_original": "Adult recommended starting dose: 5 mg once daily with maximum dose 10 mg once daily. ( 2.1 ) Small, fragile, or elderly patients, or patients with hepatic insufficiency may be started on 2.5 mg once daily. ( 2.1 ) Pediatric starting dose: 2.5 mg to 5 mg once daily. ( 2.2 ) Important Limitation: Doses in excess of 5 mg daily have not been studied in pediatric patients. ( 2.2 )",
    "warningsAndPrecautions_original": "2.5 mg Tablets\n                  Amlodipine besylate tablets, USP 2.5 mg (amlodipine besylate equivalent to 2.5 mg of amlodipine per tablet) are supplied as white to off white, round, flat-faced, beveled edge tablets '211' debossed on one side and plain on the other side and supplied as follows:\n                  NDC: 70518-1971-00\n                  NDC: 70518-1971-01\n                  NDC: 70518-1971-02\n                  PACKAGING: 30 in 1 BLISTER PACK\n                  PACKAGING: 90 in 1 BOTTLE PLASTIC\n                  PACKAGING: 30 in 1 BLISTER PACK\n                  \n                  Storage\n                  Store at 20\u00b0 to 25\u00b0C (68\u00b0 to 77\u00b0F), excursions permitted to 15\u00b0 to 30\u00b0C (59\u00b0 to 86\u00b0F) (see USP Controlled Room Temperature), and dispense in tight, light resistant container (USP).\n                  \n                  Repackaged and Distributed By:\n                  Remedy Repack, Inc.\n                  625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762",
    "adverseReactions_original": "Amlodipine besylate tablets are contraindicated in patients with known sensitivity to amlodipine.",
    "drug": [
        {
            "name": "Amlodipine Besylate",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_2668"
        }
    ]
}